Who Is in the Driver's Seat: Tracing Cancer Genes Using CRISPR-Barcoding

Abstract

Intratumor heterogeneity is thought to be the driving force of tumor evolution and therapy resistance. Yet tools to study these processes are limited. In this issue, Guernet et al. (2016) devised clustered regularly interspaced short palindromic repeats (CRISPR)-barcoding to functionally annotate specific mutations and study clonal evolution in heterogeneous cell populations.

Keywords

Molecular Biology, Cell Biology, Journal Article

Citation

Drost, J & Clevers, H 2016, 'Who Is in the Driver's Seat : Tracing Cancer Genes Using CRISPR-Barcoding', Molecular Cell, vol. 63, no. 3, pp. 352-354. https://doi.org/10.1016/j.molcel.2016.07.013